Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 14/20 | 0.77 |
| ▸ | CYP2D6 | P10635 | 13/20 | 0.66 |
| ▸ | FAP | Q12884 | 1/20 | 0.62 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.56 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28378681 | 1.00 | CYP3A4 (0.77) | CYP3A4CYP2D6FAPADORA2AADORA1 | |
| Tenofovir Anhydrous SCHEMBL497725 | 0.87 | CYP3A4 (1.00) | CYP3A4CYP2D6FAP | |
| Tenofovir Anhydrous SCHEMBL29355255 | 0.87 | CYP3A4 (1.00) | CYP3A4CYP2D6FAP | |
| Tenofovir Anhydrous SCHEMBL2040329 | 0.87 | CYP3A4 (1.00) | CYP3A4CYP2D6FAP | |
| SCHEMBL20302999 | 0.87 | CYP3A4 (0.79) | CYP3A4CYP2D6FAPADORA2AADORA1 | |
| Tenofovir Anhydrous SCHEMBL39724 | 0.87 | CYP3A4 (1.00) | CYP3A4CYP2D6FAP | |
| SCHEMBL18502993 | 0.87 | CYP3A4 (0.79) | CYP3A4CYP2D6FAPADORA2AADORA1 | |
| Tenofovir Anhydrous SCHEMBL18894359 | 0.87 | CYP3A4 (1.00) | CYP3A4CYP2D6FAP | |
| SCHEMBL24809663 | 0.86 | CYP3A4 (0.74) | CYP3A4CYP2D6FAP | |
| Tenofovir Anhydrous SCHEMBL19689138 | 0.86 | CYP3A4 (0.93) | CYP3A4CYP2D6FAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108350008-B | Novel acyclic nucleoside analogue and pharmaceutical composition thereof | 深圳市塔吉瑞生物医药有限公司 | 2020-11-03 | — | — | CN | disclosed |
| CN-108350007-B | Substituted adenine compound and pharmaceutical composition thereof | 深圳市塔吉瑞生物医药有限公司 | 2020-04-10 | — | — | CN | disclosed |
| CN-105646585-A | Preparation method of (R)-9-[2-(phosphoryl methoxyl)propyl]-adenine | 扬州三友合成化工有限公司 | 2016-06-08 | — | — | CN | disclosed |